Biosurgery - Global Strategic Business Report

Report
179 Pages
April 2024
Region: Global
Global Industry Analysts, Inc
ID: 4804723

Global Biosurgery Market to Reach $16.6 Billion by 2030

The global market for Biosurgery estimated at US$11.8 Billion in the year 2022, is projected to reach a revised size of US$16.6 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2022-2030. Bone Graft Substitutes, one of the segments analyzed in the report, is projected to record a 4.2% CAGR and reach US$6.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Hemostatic Agents segment is readjusted to a revised 3.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3.5 Billion, While China is Forecast to Grow at 4% CAGR

The Biosurgery market in the U.S. is estimated at US$3.5 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.8% and 3.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Select Competitors (Total 12 Featured) -

B. Braun Melsungen AG
BARD, A Becton, Dickinson Company
Baxter International, Inc.
Cohera Medical, Inc.
CryoLife, Inc.
Hemostasis, LLC
Integra LifeSciences Holdings Corporation
Johnson & Johnson
MAQUET Holding B.V. & Co. KG
Medtronic PLC
Pfizer, Inc.
Sanofi U.S.
Stryker Corporation

What's New?

Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and Research Platform
Complimentary updates for one year

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Biosurgery Market to Witness Steady Growth
Percentage Market Share of Worldwide Bio-Surgeries by Country: 2015 and 2022
Bone Graft Substitutes to Account for Largest Share
North American Region to Dominate Market Growth
Worldwide Biosurgery Market: Breakdown of Total Sales Value (in Billion USD) by Region: 2015 and 2022
Biosurgery - Global Key Competitors Percentage Market Share in 2022 (E)
A Prelude into Leading Players
Global Biosurgery Market: Percentage Breakdown of Market Shares by Leading Players: 2018
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

New Approvals to Support Market Growth
Various Strategies from Leading Players to Bolster Market Growth
Rapid Growth in Ageing Population Drives Market Growth
Global Population Statistics and Estimates for the 60+ Age Group (1990, 2015, 2050E, 2100E)
Rise in Worldwide Surgical Procedures to Fuel Market Growth
Total Number of Surgical Procedures Performed (in Millions) Per Annum in the US: 1981-2015
Total Number of Surgical Procedures Performed for Inpatients in Europe per Annum: 2001-2015
Rising Incidence of Injuries due to Trauma Supports Market Growth
Myriad Health End-Users to Drive Market Growth
Percentage Breakdown of Biosurgery Market Shares by Application: 2018
Percentage Growth Rate of Various Bio-Surgical Products in Wound-Closure Segment: 2011-2017
Innovations to Spur Market Growth
Total Sales of DermaPure: 2016-2018

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for Biosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 2: World Historic Review for Biosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 3: World 16-Year Perspective for Biosurgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
Table 4: World Recent Past, Current & Future Analysis for Surgical Sealing Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 5: World Historic Review for Surgical Sealing Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 6: World 16-Year Perspective for Surgical Sealing Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 7: World Recent Past, Current & Future Analysis for Hemostatic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 8: World Historic Review for Hemostatic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 9: World 16-Year Perspective for Hemostatic Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 10: World Recent Past, Current & Future Analysis for Anti-Adhesion Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 11: World Historic Review for Anti-Adhesion Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 12: World 16-Year Perspective for Anti-Adhesion Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 13: World Recent Past, Current & Future Analysis for Bone Graft Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 14: World Historic Review for Bone Graft Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 15: World 16-Year Perspective for Bone Graft Substitutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 16: World Biosurgery Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
Table 17: World Recent Past, Current & Future Analysis for Soft Tissue Attachments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 18: World Historic Review for Soft Tissue Attachments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 19: World 16-Year Perspective for Soft Tissue Attachments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 20: World Recent Past, Current & Future Analysis for General Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 21: World Historic Review for General Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 22: World 16-Year Perspective for General Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 23: World Recent Past, Current & Future Analysis for Orthopedic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 24: World Historic Review for Orthopedic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 25: World 16-Year Perspective for Orthopedic Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 26: World Recent Past, Current & Future Analysis for Reconstructive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 27: World Historic Review for Reconstructive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 28: World 16-Year Perspective for Reconstructive Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 29: World Recent Past, Current & Future Analysis for Gynecological Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 30: World Historic Review for Gynecological Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 31: World 16-Year Perspective for Gynecological Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 34: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 35: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 36: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 37: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 38: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 39: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 40: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
Table 41: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 42: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
Table 43: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

UNITED STATES

Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)

CANADA

JAPAN

Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)

CHINA

Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)

EUROPE

Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)

FRANCE

Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)

GERMANY

Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)

ITALY

UNITED KINGDOM

Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)

REST OF EUROPE

ASIA-PACIFIC

Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)

REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

B. Braun Melsungen AG
BARD, A Becton, Dickinson Company
Baxter International, Inc.
Cohera Medical, Inc.
CryoLife, Inc.
Hemostasis, LLC
Integra LifeSciences Holdings Corporation
Johnson & Johnson
MAQUET Holding B.V. & Co. KG
Medtronic PLC
Pfizer, Inc.
Sanofi U.S.
Stryker Corporation

Table Information

Report Attribute	Details
No. of Pages	179
Published	April 2024
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 11.8 Billion
Forecasted Market Value ( USD ) by 2030	$ 16.6 Billion
Compound Annual Growth Rate	4.4%
Regions Covered	Global

PURCHASE OPTIONS

Single User License PDF

1 - 10 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4828EUR$4,950USD£4,122GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€9174EUR$9,405USD£7,833GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€14485EUR$14,850USD£12,367GBP

Global Biosurgery Market to Reach $16.6 Billion by 2030

The U.S. Market is Estimated at $3.5 Billion, While China is Forecast to Grow at 4% CAGR

Select Competitors (Total 12 Featured) -

What's New?

Table of Contents

Companies Mentioned (Partial List)

Table Information

Related Topics

Related Reports

Global Biosurgery Market by Product (Adhesion Barriers, Bone Graft Attachments, Hemostatic Agents), Source (Biologics Products, Synthetic Products), Application, End-Users - Forecast 2024-2030

Biosurgery Global Market Report 2024

Global Biosurgery Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Global Biosurgery Market Report and Forecast 2023-2031

Global Biosurgery Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028